Biofrontera receives Nasdaq deficiency notice for equity below $2.5M

Biofrontera Inc.

Stockholders' equity at $469,000, well below Nasdaq's $2.5M minimum requirement.
Company has 45 days to submit a compliance plan to Nasdaq.
If plan accepted, Nasdaq may grant up to 180 days from May 21, 2025 to regain compliance.
Alternative market value or net income criteria also not met.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.